Guardant Health
GH
#1704
Rank
$12.58 B
Marketcap
$94.92
Share price
-3.79%
Change (1 day)
134.60%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -$3.39

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -$3.39. In 2025 the company made an earnings per share (EPS) of -$3.31 an increase over its 2024 EPS that were of -$3.56.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$3.392.42%
2025-$3.31-7.02%
2024-$3.56-16.82%
2023-$4.28-33.13%
2022-$6.4060%
2021-$4.0055.04%
2020-$2.58207.14%
2019-$0.84-19.81%
2018-$1.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-$2.81-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-$2.48-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA